Congenital heart disease

Cumulative Radiation Exposure and Lifetime Cancer Risk in Patients With Tetralogy of Fallot Requiring Early Intervention

JACC AdvPublished Retrospective cohort study

Authors' conclusion

Cumulative radiation exposure and LARs were higher among those undergoing SR compared to PR.

Study context

Population
Neonates with tetralogy of Fallot and symptomatic cyanosis (sTOF) requiring early intervention, Congenital Cardiac Research Collaborative, 2012–2017
Participants
242 neonates8 centres
Exposure
Staged repair vs primary repair
  • Staged repair (SR)n = 146
  • Primary repair (PR)n = 96reference
Outcome
Cumulative radiation exposure (total effective dose) and associated LAR of cancer
Follow-up
Prior to 18 months of age
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

Cumulative total effective dose

SR

8.3

median · IQR 3.0–17.4 · mSv

PR

2.1

IQR 0.8–8.5 · mSv

P < 0.001

Observational data: associations, not effects.

Further findings

Lifetime attributable risk (LAR) of breast cancer in females (organs with median exposure >1 mGy) — SR
mean 1.9 /1,000 patients
Proportion of thyroid cancers attributable to radiation, females — SR
7.3%
  • LAR of breast cancer in females (organs with median exposure >1 mGy): highest LAR among organs with median exposure >1 mGy in females
  • Proportion of thyroid cancers attributable to radiation, females: highest projected proportion of cancers attributable to radiation

Cumulative organ-level doses

Significantly higher in SR compared to PR

LAR of cancer by sex

Regardless of treatment strategy, LARs higher in females than males

Original publication

Cumulative Radiation Exposure and Lifetime Cancer Risk in Patients With Tetralogy of Fallot Requiring Early Intervention. JACC Adv. Published 6 September 2024. doi:10.1016/j.jacadv.2024.101239

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.